Maria Banzi

2.5k total citations
49 papers, 500 citations indexed

About

Maria Banzi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Maria Banzi has authored 49 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Maria Banzi's work include Colorectal Cancer Treatments and Studies (29 papers), Cancer Treatment and Pharmacology (11 papers) and Gastric Cancer Management and Outcomes (10 papers). Maria Banzi is often cited by papers focused on Colorectal Cancer Treatments and Studies (29 papers), Cancer Treatment and Pharmacology (11 papers) and Gastric Cancer Management and Outcomes (10 papers). Maria Banzi collaborates with scholars based in Italy, Spain and Belgium. Maria Banzi's co-authors include C. Boni, L Piccinini, Alessandra Bisagni, Maria Cecilia Mengoli, Giulio Rossi, Mario Criscuolo, Vittorio Silingardi, S. Zironi, Antonio Frassoldati and Caterina Longo and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Maria Banzi

45 papers receiving 493 citations

Peers

Countries citing papers authored by Maria Banzi

Since Specialization

Citations

This map shows the geographic impact of Maria Banzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Banzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Banzi more than expected).

Fields of papers citing papers by Maria Banzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Banzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Banzi. The network helps show where Maria Banzi may publish in the future.

Co-authorship network of co-authors of Maria Banzi

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Banzi. A scholar is included among the top collaborators of Maria Banzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Banzi. Maria Banzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of different clinical presentations of Merkel cell carcinomas and their potential prognostic implications 2025 ·Clinical and Experimental Dermatology ·Michela Lai, Simonetta Piana, Gabriella Brancaccio, (unknown), (unknown), Margherita Raucci, Andrea Ronchi, Alessandro Zerbini, Chiara Carone, Maria Banzi, Shaniko Kaleci, Giuseppe Argenziano, Caterina Longo	0
2	Impact of Multidisciplinary Team Management on Survival and Recurrence in Stage I–III Colorectal Cancer: A Population-Based Study in Northern Italy 2024 ·Biology ·Lucìa Mangone, Maurizio Zizzo, (unknown), (unknown), (unknown), (unknown), Maria Banzi, Angela Damato, (unknown), (unknown), Fortunato Morabito, Antonino Neri, Massimiliano Fabozzi, Carmine Pinto, Paolo Giorgi Rossi	4
3	Characteristics and Outcomes of Colorectal Cancer Patients Cared for by the Multidisciplinary Team in the Reggio Emilia Province, Italy 2024 ·Cancers ·Lucìa Mangone, (unknown), (unknown), (unknown), Maria Banzi, Angela Damato, V. Iori, Carmine Pinto, (unknown), (unknown), Maurizio Zizzo, Fortunato Morabito, Antonino Neri, Paolo Giorgi Rossi	3
4	Clinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center 2023 ·Dermatology Practical & Conceptual ·(unknown), Giacomo Santandrea, Michela Lai, Stefania Borsari, Shaniko Kaleci, Maria Banzi, Vincenzo Dario Mandato, Giovanni Pellacani, Simonetta Piana, Caterina Longo	0
5	Characteristics and management of skin cancers in very elderly patients: A real‐world challenge for clinicians 2022 ·Experimental Dermatology ·Michela Lai, Riccardo Pampena, (unknown), Margherita Raucci, Elisa Benati, Stefania Borsari, Mara Lombardi, Maria Banzi, Fabio Castagnetti, (unknown), Simonetta Piana, (unknown), Giovanni Pellacani, Caterina Longo	6
6	Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy) 2021 ·Targeted Oncology ·Massimo Aglietta, Vanna Chiarion‐Sileni, Paolo Fava, Massimo Guidoboni, Roberta Depenni, Alessandro Marco Minisini, Francesca Consoli, Paolo A. Ascierto, Gaetana Rinaldi, Maria Banzi, Riccardo Marconcini, (unknown), Virginia Ferraresi, Marco Tucci, Giuseppe Tonini, Re G, Michele Guida, Michele Del Vecchio, Ilaria Marcon, Paola Queirolo	5
7	Italian Results of the PRECONNECT Study: Safety and Efficacy of Trifluridine/tipiracil in Metastatic Colorectal Cancer 2021 ·Future Oncology ·Alberto Zaniboni, Carlo Barone, Maria Banzi, Francesca Bergamo, Livio Blasi, Roberto Bordonaro, Maria Di Bartolomeo, Francesco Di Costanzo, Giovanni Luca Frassineti, Carlo Garufi, Francesco Giuliani, Tiziana Pia Latiano, Erika Martinelli, Nicola Personeni, Patrizia Racca, Emiliano Tamburini, Giuseppe Tonini, (unknown), (unknown), Alfredo Falcone	6
8	Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study 2021 ·Clinical Colorectal Cancer ·Eleonora Lai, Marco Puzzoni, Pina Ziranu, Chiara Cremolini, Sara Lonardi, Maria Banzi, Stefano Mariani, Nicole Liscia, Saverio Cinieri, (unknown), Manlio Mencoboni, Floriana Nappo, (unknown), Roberto Labianca, (unknown), Alessandra Boccaccino, Veronica Conca, Valeria Pusceddu, Alberto Zaniboni, Mario Scartozzi	2
9	399O Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trial 2020 ·Annals of Oncology ·Gerardo Rosati, Francesca Galli, Sara Lonardi, Katia Dotti, Monica Ronzoni, Maria Giulia Zampino, Maria Banzi, Valeria Pusceddu, Felice Pasini, Silvia Bozzarelli, Nicoletta Pella, Carla Codecà, Vincenzo Montesarchio, Andrea Mambrini, Alfonso De Stefano, L. Ciuffreda, Sara Elena Rebuzzi, Domenico Bilancia, Roberto Labianca	1
10	Nab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial 2019 ·Annals of Oncology ·Stefano Cascinu, Rossana Berardi, Roberto Bianco, Domenico Bilancia, Alberto Zaniboni, Daris Ferrari, Stefania Mosconi, Andrea Spallanzani, Luigi Cavanna, Silvana Leo, Francesca Negri, Giordano Beretta, Alberto F. Sobrero, Maria Banzi, Alberto Morabito, Alessandro Bittoni, Roberta Marciano, (unknown), (unknown), Maria Carmela Piccirillo	4
11	Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer 2017 ·British Journal of Cancer ·Federica Marmorino, Lisa Salvatore, C. Barbara, Giacomo Allegrini, Lorenzo Antonuzzo, Gianluca Masi, Fotios Loupakis, Beatrice Borelli, Silvana Chiara, Maria Banzi, (unknown), D. Amoroso, (unknown), Andrea Bonetti, Angelo Martignetti, Myriam Paris, (unknown), Luca Boni, Alfredo Falcone, Chiara Cremolini	33
12	FOLFOX4/XELOX in stage II–III colon cancer: Efficacy and safety results of the Italian Three Or Six Colon Adjuvant (TOSCA) trial 2017 ·Annals of Oncology ·Roberto Labianca, Sara Lonardi, Gerardo Rosati, Maria Di Bartolomeo, Monica Ronzoni, Nicoletta Pella, Mario Scartozzi, Maria Banzi, Maria Giulia Zampino, Felice Pasini, Paolo Marchetti, Maurizio Cantore, Alberto Zaniboni, Lorenza Rimassa, L. Ciuffreda, Sandro Barni, Vittorina Zagonel, Evaristo Maiello, Eliana Rulli, Alberto F. Sobrero	2
13	Review of RAISE, a Randomized, Double-Blind, Multicenter Phase III Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (RAM) or Placebo (PBO) in Patients (pts) With Metastatic Colorectal Carcinoma (mCRC) Progressive During or Following First-Line Combination Therapy With Bevacizumab (bev), Oxaliplatin (ox), and a Fluoropyrimidine (fp): Primary Results and Subgroup Analysis by KRAS Status 2015 ·Annals of Oncology ·Alberto Sobrero, Luciano Latini, C. Barone, (unknown), Maria Banzi, Federico Nasroulah, (unknown), Josep Tabernero	1
14	Regorafenib for previously treated metastatic colorectal cancer (mCRC): results from 683 Italian patients treated in the open-label phase IIIB CONSIGN study 2015 ·Annals of Oncology ·Fortunato Ciardiello, Lisa Salvatore, Stefano Cascinu, Alberto Sobrero, Maria Banzi, Carlo Barone, Andrea Spallanzani, Tiziana Latiano, Alessio Amatu, Vittorina Zagonel, M. Biglietto, Francesco Di Costanzo, Maria Di Bartolomeo, Armando Santoro, Antonio Russo, M. Moscovici, Eric Van Cutsem, Alberto Zaniboni	3
15	Concomitant EGFR mutation and ALK rearrangement in lung adenocarcinoma is more frequent than expected: Report of a case and review of the literature with demonstration of genes alteration into the same tumor cells 2014 ·Lung Cancer ·(unknown), Maria Cecilia Mengoli, Alessandra Bisagni, Maria Banzi, C. Boni, Giulio Rossi	55
16	A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma 2013 ·The Oncologist ·Lorenza Rimassa, Tiziana Pressiani, C. Boni, Carlo Carnaghi, Elena Rota Caremoli, S. Fagiuoli, Paolo Foa, Stefania Salvagni, Enrico Cortesi, Maria Chiara Tronconi, Nicola Personeni, Silvia Bozzarelli, Maria Banzi, Silvia Fanello, Romano Fabio Lutman, Laura Giordano, Armando Santoro	29
17	Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Receiving a First-Line Treatment Containing Bevacizumab: Update of Bebyp Trial by Gono 2013 ·Annals of Oncology ·Lisa Salvatore, Gianluca Masi, Fotios Loupakis, Chiara Cremolini, Marta Schirripa, Lorenzo Fornaro, Cristina Granetto, (unknown), Francesco Di Costanzo, Lorenzo Antonuzzo, Lorenzo Marcucci, Samanta Cupini, C. Boni, Maria Banzi, Silvana Chiara, (unknown), C. Valsuani, Andrea Bonetti, Luca Boni, Alfredo Falcone	2
18	Epidermal growth factor receptor (EGFR) gene copy number in colorectal adenoma-carcinoma progression 2012 ·Cancer Genetics ·Marcella Flora, Simonetta Piana, (unknown), Alessandra Bisagni, Loredana De Marco, Alessia Ciarrocchi, (unknown), Giorgio Gardini, Ione Tamagnini, Maria Banzi, Giancarlo Bisagni	10
19	The Role of Cetuximab in Pre-Treated Refractory Patients with Metastatic Colorectal Cancer: Outcome Study in Clinical Practice 2008 ·Journal of Chemotherapy ·G. Lelli, (unknown), (unknown), Benedetta Urbini, Francesco Bonetti, (unknown), Guido Biasco, Maria A. Pantaleo, Alba A. Brandes, C. Calandri, (unknown), Oriana Nanni, C. Boni, Maria Banzi, Francesca Negri, (unknown), Francesca Di Fabio, D. Turci	4
20	Changes of biological features in breast cancer cells determined by primary chemotherapy 1997 ·Breast Cancer Research and Treatment ·Antonio Frassoldati, (unknown), Maria Banzi, Mario Criscuolo, L Piccinini, Vittorio Silingardi	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact